Octreotide is a derivative of artificially modified natural somatostatin, which is an octapeptide. Its physiological effects include inhibiting growth hormone function, inhibiting the secretion of gastric acid, pancreatic enzymes, glucagon and insulin, reducing visceral blood flow, reducing gastrointestinal motility, etc. It is clinically used for emergency treatment of esophageal-varices bleeding, treatment of acromegaly and treatment related to gastrointestinal endocrine tumors. Its product SANDOSTATIN was developed by Novartis Pharma Schweiz AG and was approved to enter the Chinese market in 2003. Since then, some generic drugs have also been listed in the Chinese market. By 2020, there are several manufacturers in the Chinese Octreotide market, among which Novartis Pharma Schweiz AG accounts for the most market share.
According to CRI’s market research, the sales value of Octreotide in the Chinese market from 2016 to 2019 were relatively stable. In 2020, due to the impact of COVID-19 on the overall diagnosis and treatment services of the hospital, the sales value of Octreotide in the Chinese market decreased to CNY690 million, a year-on-year decrease of 3.8%. From 2016 to 2020, the CAGR of Octreotide sales value in the Chinese market is -0.48%.
CRI expects that with the relief of COVID-19, the sales value of Octreotide in the Chinese market will have a restorative growth from 2021 to 2025. In addition, compared with similar drugs, Octreotide has a longer action time, not only can extensively inhibit the secretion of digestive juice, but also promotes the absorption of digestive juice by the intestinal mucosa. Based on these advantages, the sales value and sales volume of Octreotide still has room to rise. At the same time, in recent years, the pace of life of Chinese residents has accelerated, and irregular eating habits have increased the prevalence of various gastrointestinal diseases. Therefore, the demand for Octreotide will continue to expand and its sales value will continue to grow from 2021 to 2025.
- -The impact of COVID-19 on China’s Octreotide market
- – Sales value of China’s Octreotide 2016-2020
- – Competitive landscape of China’s Octreotide market
- – Prices of Octreotide in China
- – Prices of Octreotide in China by regions and manufacturers
- – Analysis on factors affecting the development of China’s Octreotide market
- – Prospect of China’s Octreotide market from 2021 to 2025